StemoniX Revenue and Competitors

Claim your profile



Total Funding



Estimated Revenue & Valuation

  • StemoniX's estimated annual revenue is currently $1.6M per year.(i)
  • StemoniX's estimated revenue per employee is $77,500
  • StemoniX's total funding is $37.6M.

Employee Data

  • StemoniX has 20 Employees.(i)
  • StemoniX grew their employee count by -41% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

Our mission is to accelerate the discovery of new medicines with physiologically-relevant, structured human cells that improve cell-based assay outcomes. We develop and scalably manufacture human induced pluripotent stem (iPS) cell-derived cardiac and neuronal platforms for drug discovery and development. Predictive, accurate, and consistent, our human models enable scientists to quickly and economically conduct research with improved outcomes in a simplified workflow. We also collaborate with drug discovery organizations to test their compounds with our in-house screening capabilities, create new cell-based models, and operationalize their human iPS cells at large scale for high throughput screening. StemoniX microHeart® products in high density plate formats provide researchers with structurally aligned cardiac cells resembling native human heart tissue with accelerated features of cell maturity. StemoniX microBrain® products in high density formats are physiologically relevant with biology, activity, functional maturity that mimic native human brain tissue. Available pre-plated to simplify your workflow, microHeart and microBrain are delivered in ambient conditions and ready for assay use soon after delivery. With leading-edge iPSC technologies, we are helping global institutions bring the most promising medicines to patients. Contact us at to discuss how StemoniX products and services can accelerate your discoveries.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





StemoniX News

2022-04-13 - Vyant Bio (NASDAQ:VYNT) Downgraded by Zacks Investment ...

StemoniX is empowering the discovery of new medicines through the convergence of novel human biology and software technologies. vivoPharm offers...

2021-01-12 - StemoniX to Participate in Biotech Showcase(TM) Digital 2021

Maple Grove, Minnesota--(Newsfile Corp. - January 11, 2021) - StemoniX, a biotech company changing how new drugs are discovered, announced today their participation at the 2021 Biotech Showcase™ being held January 11-15th as part of OrganAi, a joint venture between StemoniX and Atomwise. The com ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding